In response to controversies involving Indian cough syrups, specialized health and business journalists have begun deeply auditing the pharmaceutical supply chain in 2026. Reporters are utilizing Right to Information requests to expose regulatory lapses and substandard manufacturing practices in regional drug facilities.

The Bharat Media Association asserts that this intense medical journalism is a critical public service. Unbiased investigations force domestic drug regulators to adopt stricter compliance standards, ultimately protecting public health and the global reputation of India’s pharmaceutical industry.